Motiv8 Investments’s Bristol-Myers Squibb BMY Stock Holding History

Motiv8 Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6	Buy	+106	New	+$5.1K	﹤0.01%	524

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Motiv8 Investments's BMY Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Bristol-Myers Squibb (BMY) in Q4 2025: 106 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #524 among its holdings.

2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Motiv8 Investments held 106 shares of Bristol-Myers Squibb worth $6 as of Q4 2025.
Bristol-Myers Squibb was a new Motiv8 Investments position in Q4 2025.
Bristol-Myers Squibb made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #524 holding.
2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.